UPDATE – OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results
OptimizeRx(US:OPRX) Globenewswire·2026-03-05 22:04- Q4 revenue of $32.2 million- Q4 gross profit increased 9% year-over-year to $24.1 million- Q4 net income and adjusted EBITDA hit records at $5.0 million and $12.0 million, respectively- Updating 2026 revenue guidance to $109-$114 million and adjusted EBITDA guidance to $21-$25 million- Paid off an incremental $2 million in principal from term loan during Q4- OptimizeRx's Board authorizes a $10 million share repurchase program WALTHAM, Mass., March 05, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Compa ...